Skip to main content
Domainex
  • About
    • About
    • Track Record
    • Case Studies
    • Testimonials
    • Awards & Accreditations
    • Management team
    • Board members
    • Investors
    • Contact us
  • Services
    • Offerings
      • Offerings
      • ADME and Bioanalytical Sciences
      • Analytical Chemistry
      • Assay Development
      • Biochemical Assays
      • Biophysical Assays
      • Cell Based Assays
      • Computational Chemistry
      • Fragment and Compound Screening
      • Integrated Drug Discovery Services
      • Medicinal Chemistry
      • Project Management and Consultancy Services
      • Protein Expression and Purification Services
      • Structural Biology
      • Synthetic Chemistry
      • Virtual screening
    • Research Phases
      • Research Phases
      • Hit Identification
      • Hit to Lead
      • Lead Optimisation
    • Therapeutic Areas
      • Therapeutic Areas
      • Anti-infectives
      • Cardiovascular
      • CNS drug discovery
      • Immuno-Oncology
      • Inflammatory diseases
      • Oncology
      • Respiratory
    • Target Classes
      • Target Classes
      • Biotherapeutics
      • Covalent Inhibitors
      • GPCRs
      • Ion Channels
      • Kinases
      • Methyltransferases
      • Molecular glues
      • Proteases
      • Protein-Protein Interactions
      • Targeted Protein Degradation
    • Approaches & Techniques
      • Approaches & Techniques
      • CDH (Target Gene Fragmentation)
      • Cryogenic Electron Microscopy (Cryo-EM)
      • Differential Scanning Fluorimetry (DSF) and nanoDSF Services
      • Direct-to-Biology (D2B)
      • Dynamic Light Scattering (DLS)
      • eProtein Discovery
      • Flow Cytometry
      • Fragment Based Drug Discovery (FBDD)
      • FragmentBuilder
      • Grating-Coupled Interferometry
      • High Throughput Screening
      • Isothermal Titration Calorimetry (ITC)
      • LeadBuilder
      • PoLiPa (Membrane Protein Solubilisation)
      • Spectral Shift and MST Services
      • Structure Based Drug Design (SBDD)
      • Surface Plasmon Resonance (SPR)
      • X-ray Crystallography
  • Library
    • Articles
    • Brochures
    • Newsletters
    • Posters
    • Presentations & Videos
    • Publications
    • White Papers
    • Webinars
  • News & Events
  • Careers
  • English
  • French
  • Spanish
  • German
  • Italian
  • Japanese
  • Dutch
  • USA
Enquire

ON Helix 2025

Thursday, 3 Jul '25

ON Helix is a one-day conference addresses key bio innovation trends, from developments in life science and technology research to their translation into new diagnostics, prevention tools or treatments.

Get in touch if you would like to meet us there.

News

Medicinal Chemistry in Review: The Discovery of Elironrasib (RMC-6291)

17 Jun '25
Blog Post

Domainex Supports Sitryx's MTHFD2 Programme Resulting in the Nomination of Development Candidate, SIT047

20 May '25
News Article

Domainex Appoints Hayley French as Chief Executive Officer

7 May '25
Press Release
View more

Upcoming Events

Jul 3 ON Helix 2025

Jul 21 28th International symposium: Synthesis in organic chemistry

Sep 14 RSC-BMCS / SCI 23rd Medicinal Chemistry Symposium

View more

Start your next project with Domainex

Contact one of our experts today
Domainex

+44(0) 1223 433180 enquiries@domainex.co.uk

Cyber Essentials - Certified Plus

Domainex is a registered company (number 4336899)

Site and its contents Copyright © Domainex 2025. All rights reserved.

Terms and Conditions | Privacy Policy